| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5671533 | Clinical Microbiology and Infection | 2017 | 21 Pages |
Abstract
In the absence of data from randomized controlled trials recommendations cannot be made for or against either of the studied regimens in this group of hospitalized patients with CAP. Well designed randomized controlled trials comparing the two regimens are warranted.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
K.Z. Vardakas, K.K. Trigkidis, M.E. Falagas,